Detalle Publicación

ARTÍCULO
The current role of the heavy/light chain assay in the diagnosis, prognosis and monitoring of multiple myeloma: an evidence-based approach
Autores: Ríos-Tamayo, R. (Autor de correspondencia); Puig, N.; Algarín, M.; García de Veas Silva, J. L.; Barbosa, N.; Encinas, C.; Hernández, J. A.; Alonso, R.; Campos, M. L.; Rodríguez, T.; Leivas, A.; Olivares, M. J.; Sánchez, M. J.; Paiva, Bruno; Lahuerta, J. J.; Martínez-López, J.
Título de la revista: DIAGNOSTICS
ISSN: 2075-4418
Volumen: 11
Número: 11
Páginas: 2020
Fecha de publicación: 2021
Lugar: WOS
Resumen:
Despite tremendous progress being made in recent years, multiple myeloma (MM) remains a challenging disease. The laboratory plays a critical role in the overall management of patients. The diagnosis, prognosis, clinical monitoring and evaluation of the response are key moments in the clinical care process. Conventional laboratory methods have been and continue to be the basis of laboratory testing in monoclonal gammopathies, along with the serum free light chain test. However, more accurate methods are needed to achieve new and more stringent clinical goals. The heavy/light chain assay is a relatively new test which can overcome some of the limitations of the conventional methods for the evaluation of intact immunoglobulin MM patients. Here, we report an update of the evidence accumulated in recent years on this method regarding its use in MM.